Diabetic Cardiology
Autor: | Miles Fisher, John J. McMurray |
---|---|
EAN: | 9780470862056 |
eBook Format: | |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 28.02.2008 |
Kategorie: | |
Schlagworte: | diabetes; cardiovascular disease; death; common; people; cause; treatment; heart disease; factors; many; reawakened; several; studies; results; multicentre; endpoints; cardiovascular; type; ukpds; significantly; reduce; blood pressure |
116,99 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
The DIGAMI study on the use of intravenous insulin infusion at the time of myocardial infarction (MI) has stimulated a large number of discussion papers on the best treatment of MI in the diabetic patient. The UKPDS has shown that treatment of Type 2 diabetes does not reduce cardiovascular end-points significantly, but that aggressive treatment of blood pressure can do so. In addition, sub-group analysis from several large cardiovascular trials has shown that treatment with statins, anti-platelet therapy, ACE inhibitors and other drugs will also reduce cardiovascular events in people with diabetes.
Miles Fisher, Consultant Physician, Glasgow Royal Infirmary
John McMurray, Professor of Medical Cardiology, British Heart Foundation Cardiovascular Research Centre, University of Glasgow and Honorary Consultant Cardiologist, Western Infirmary, Glasgow